Calliditas Therapeutics AB Total Assets

As of the most recent data (June 2024), CALT shows a total assets of $1.7B. That compares with $1.7B in the prior-year period — up 2.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CALT's total assets is now $1.7B (was $1.7B) — a 2.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Calliditas Therapeutics AB is outperforming or lagging.

Tracking CALT's total assets over time shows whether Calliditas Therapeutics AB is scaling, shrinking, or reshaping that part of the business. The current reading is $1.7B That compares with $1.7B in the prior-year period — up 2.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Calliditas Therapeutics AB's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $1.7B) with ownership activity and broader fundamentals.

Calliditas Therapeutics AB's total assets is $1.7B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.